Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=201"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=201

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT03354598-sae",
        "title": "Sulopenem-etzadroxil/Probenecid vs Ciprofloxacin: serious adverse events",
        "summary": "6 of 833 against 2 of 827; risk difference 0.5 points, 95% interval -0.3 to 1.3; NCT03354598, Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women",
        "record": "/library/comparisons/NCT03354598-sae",
        "nct_id": "NCT03354598",
        "kind": "serious-adverse-events",
        "participants": 1660,
        "risk_difference": {
          "value": 0.004784501466850343,
          "lower": -0.002671525568004025,
          "upper": 0.013387373281045738
        },
        "group_1": "6 of 833",
        "group_2": "2 of 827",
        "difference": "0.5 points",
        "interval": "-0.3 to 1.3",
        "trial_title": "Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women"
      },
      {
        "id": "NCT03244189-354c2f44",
        "title": "Intervention vs Control: Number of Participants With a Symptomatic Stone Event",
        "summary": "154 of 826 against 165 of 832; risk difference -1.2 points, 95% interval -5.0 to 2.6; NCT03244189, Prevention of Urinary Stones With Hydration",
        "record": "/library/comparisons/NCT03244189-354c2f44",
        "nct_id": "NCT03244189",
        "kind": "outcome",
        "participants": 1658,
        "risk_difference": {
          "value": -0.011876629726205984,
          "lower": -0.04980974062359413,
          "upper": 0.02610872539733035
        },
        "group_1": "154 of 826",
        "group_2": "165 of 832",
        "difference": "-1.2 points",
        "interval": "-5.0 to 2.6",
        "trial_title": "Prevention of Urinary Stones With Hydration"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=202",
  "request_id": "14EqDV1eLyJghXvs"
}